Anti-MMP7 antibody [EPR17888-101]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(30 Publications)
Rabbit Recombinant Monoclonal MMP7 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 30 publications.
View Alternative Names
MPSL1, PUMP1, MMP7, Matrilysin, Matrin, Matrix metalloproteinase-7, Pump-1 protease, Uterine metalloproteinase, MMP-7
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MMP7 antibody [EPR17888-101] (AB205525)
Immunohistochemical analysis of paraffin-embedded Human liver tissue labeling MMP7 with ab205525 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. No staining on Human liver tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MMP7 antibody [EPR17888-101] (AB205525)
Immunohistochemical analysis of paraffin-embedded Human stomach carcinoma tissue labeling MMP7 with ab205525 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on Human gastric carcinoma tissue is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MMP7 antibody [EPR17888-101] (AB205525)
Immunohistochemical analysis of paraffin-embedded Human prostatic carcinoma tissue labeling MMP7 with ab205525 at 1/2000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Cytoplasmic staining on Human prostatic carcinoma is observed. Counter stained with Hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- WB
Supplier Data
Western blot - Anti-MMP7 antibody [EPR17888-101] (AB205525)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MMP7 antibody [EPR17888-101] (ab205525) at 1/1000 dilution
Lane 1:
Human colon cancer lysate at 10 µg
Lane 2:
Human tonsil lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-MMP7 antibody [EPR17888-101] (AB205525)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MMP7 antibody [EPR17888-101] (ab205525) at 1/2000 dilution
Lane 1:
A549 (Human lung carcinoma) whole cell lysate at 20 µg
Lane 2:
BxPC-3 (Human pancreas adenocarcinoma cells) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-MMP7 antibody [EPR17888-101] (AB205525)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MMP7 antibody [EPR17888-101] (ab205525) at 1/1000 dilution
All lanes:
Human prostate lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
false
Exposure time: 5s
- WB
Collaborator
Western blot - Anti-MMP7 antibody [EPR17888-101] (AB205525)
ab205525 was shown to react with MMP7 in wild-type A549 cells in Western blot with loss of signal observed in a MMP7 knockout cell line. Wild-type A549 and MMP7 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab205525 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-MMP7 antibody [EPR17888-101] (ab205525) at 1/1000 dilution
Lane 1:
Wild-type A549 lysate at 30 µg
Lane 2:
MMP7 knock-out A549 lysate at 30 µg
false
Related conjugates and formulations (1)
-
Anti-MMP7 antibody [EPR17888-101] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MMP7 participates in wound healing embryonic development and tissue invasion processes. It does not typically form large complexes but can interact with other ECM components and inhibitors like TIMPs (tissue inhibitors of metalloproteinases). MMP7 has specific roles in regulating cellular environments by modifying the ECM and influencing the bioavailability of growth factors.
Pathways
MMP7 plays significant roles in pathways like the Wnt and MAPK signaling pathways. In the Wnt pathway MMP7 modulates the availability of bound matrix proteins influencing signaling dynamics. It interacts with proteins such as B-catenin and influences downstream gene expression. In the context of MAPK pathways MMP7 activity can lead to signal transduction changes that impact cell proliferation and migration.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (30)
Recent publications for all applications. Explore the full list and refine your search
PloS one 20:e0332396 PubMed40966274
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:8324 PubMed38594513
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 43:103 PubMed38570866
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 21:704 PubMed37814323
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology international 47:1782-1798 PubMed37434557
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 56:e13386 PubMed36564367
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 12:899 PubMed34599146
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 21:402 PubMed33717261
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cytotechnology 73:1-11 PubMed33505109
2021
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2020:8831466 PubMed33005257
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com